Search Results Search Sort by RelevanceMost Recent Case and Commentary Dec 2020 Should a Patient Who Is Pregnant and Brain Dead Receive Life Support, Despite Objection From Her Appointed Surrogate? Daniel Sperling, SJD Lack of ethical, legal, and clinical consensus about best practice sometimes combines with a poor clinical evidence base. AMA J Ethics. 2020;22(12):E1004-1009. doi: 10.1001/amajethics.2020.1004. Policy Forum Aug 2021 How Does Cost-Effectiveness Analysis Inform Health Care Decisions? David D. Kim, PhD and Anirban Basu, PhD CEA has been increasingly used to inform public and private organizations’ reimbursement decisions, benefit designs, and price negotiations worldwide. AMA J Ethics. 2021;23(8):E639-647. doi: 10.1001/amajethics.2021.639. Podcast May 2019 Ethics Talk: When and How Should ECMO Be Initiated and Removed? When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care. Medicine and Society Apr 2024 Mapping a Way to Displaced Persons’ Access to Quality Medicines Carly Ching, PhD and Muhammad H. Zaman, PhD Reliable supply of quality-assured medicines is hard to maintain in refugee camps in low- and middle-income countries with conflict zones. AMA J Ethics. 2024;26(4):E341-347. doi: 10.1001/amajethics.2024.341. Podcast Apr 2024 Ethics Talk: Supply Chain Reasons Your Pharmacy Might Not Have Your Medicine Dr Amy B. Cadwallader joins Ethics Talk to discuss how critical medicine supply chains are identified and secured.
Case and Commentary Dec 2020 Should a Patient Who Is Pregnant and Brain Dead Receive Life Support, Despite Objection From Her Appointed Surrogate? Daniel Sperling, SJD Lack of ethical, legal, and clinical consensus about best practice sometimes combines with a poor clinical evidence base. AMA J Ethics. 2020;22(12):E1004-1009. doi: 10.1001/amajethics.2020.1004.
Policy Forum Aug 2021 How Does Cost-Effectiveness Analysis Inform Health Care Decisions? David D. Kim, PhD and Anirban Basu, PhD CEA has been increasingly used to inform public and private organizations’ reimbursement decisions, benefit designs, and price negotiations worldwide. AMA J Ethics. 2021;23(8):E639-647. doi: 10.1001/amajethics.2021.639.
Podcast May 2019 Ethics Talk: When and How Should ECMO Be Initiated and Removed? When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care.
Medicine and Society Apr 2024 Mapping a Way to Displaced Persons’ Access to Quality Medicines Carly Ching, PhD and Muhammad H. Zaman, PhD Reliable supply of quality-assured medicines is hard to maintain in refugee camps in low- and middle-income countries with conflict zones. AMA J Ethics. 2024;26(4):E341-347. doi: 10.1001/amajethics.2024.341.
Podcast Apr 2024 Ethics Talk: Supply Chain Reasons Your Pharmacy Might Not Have Your Medicine Dr Amy B. Cadwallader joins Ethics Talk to discuss how critical medicine supply chains are identified and secured.